The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Drug Packaging
Hierarchy: | ∟ ∟ ∟ Drug Packaging 11 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Drug Packaging 11 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Drug Packaging 11 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Drug Packaging 11 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Drug Packaging 11 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ |
Broader terms: | |
Narrower terms: | |
Annotation: | includes containers, packaging methods, packaging materials; IM; DRUG LABELING is also available
X |
History note: | |
historyNote*: | 78; was DRUG CONTAINERS AND CLOSURES 1968-77
X |
onlineNote*: | use DRUG PACKAGING to search DRUG CONTAINERS AND CLOSURES 1968-77
X |
publicMeSHNote*: | 78; was DRUG CONTAINERS AND CLOSURES 1968-77
X |
Scope note: | Containers, packaging, and packaging materials for drugs and biological products. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available.
X |
activeMeSHYear*: | |
dateCreated*: | 1999-01-01X |
dateEstablished*: | 1968-01-01X |
dateRevised*: | 1995-06-05X |
recordAuthorizer*: | PLSX |
recordMaintainer*: | JLSX |
recordOriginator*: | NLMX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Lääkepakkaukset (fi) XLääkepakkaus (fi, replaced) Läkemedelsförpackning (sv) Packaging, Drug (en, replaced) Drug Containers (en, replaced) |
Share: |
Loading results...